Literature DB >> 2070482

Detection of DNA adducts in HL-60 cells treated with hydroquinone and p-benzoquinone by 32P-postlabeling.

G Levay1, K Pongracz, W J Bodell.   

Abstract

We have examined DNA adduct formation and cytotoxicity in HL-60 cells treated with either hydroquinone (HQ) or p-benzoquinone (p-BQ). Treatment of HL-60 cells with either HQ or p-BQ produced the same DNA adduct. The DNA adduct level varied from 0.05 to 10 adducts per 10(7) nucleotides as a function of treatment time and concentration for both compounds. To achieve the same DNA adduct level required higher concentrations and longer treatment times with HQ compared to p-BQ. p-BQ was also more cytotoxic to HL-60 cells than HQ. Reaction of calf thymus DNA with a p-BQ/HQ mixture produced five adducts as detected by 32P-postlabeling. Two isomers of (hydroxy)-1,N2-benzetheno-2'- deoxyguanosine-3'-phosphate were isolated from the reaction of 2'-deoxyguanosine-3'-phosphate with a p-BQ/HQ mixture and one of the isomers was identified as adduct no. 1 of the DNA reaction. The DNA adduct formed in HL-60 cells treated with HQ or p-BQ did not correspond to any of the principal adducts formed in DNA reacted with p-BQ/HQ. This result suggests that cellular mechanisms modify DNA adduct formation by HQ and p-BQ.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070482     DOI: 10.1093/carcin/12.7.1181

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  15 in total

1.  A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.

Authors:  Z Ji; L Zhang; V Peng; X Ren; C M McHale; M T Smith
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

2.  Botanical dietary supplements gone bad.

Authors:  Birgit Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

Review 3.  The use of biomonitoring data in exposure and human health risk assessment: benzene case study.

Authors:  Scott M Arnold; Juergen Angerer; Peter J Boogaard; Michael F Hughes; Raegan B O'Lone; Steven H Robison; A Robert Schnatter
Journal:  Crit Rev Toxicol       Date:  2013-02       Impact factor: 5.635

4.  Understanding the cytotoxicity or cytoprotective effects of biological and synthetic quinone derivatives by redox mechanism.

Authors:  Rosivaldo S Borges; Agnaldo S Carneiro; Tainá G Barros; Carlos A L Barros; Antonio M J Chaves Neto; Albérico B F da Silva
Journal:  J Mol Model       Date:  2014-12-11       Impact factor: 1.810

5.  Benzene and dopamine catechol quinones could initiate cancer or neurogenic disease.

Authors:  Muhammad Zahid; Muhammad Saeed; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2009-11-10       Impact factor: 7.376

6.  Effects of benzene metabolite treatment on granulocytic differentiation and DNA adduct formation in HL-60 cells.

Authors:  C C Hedli; N R Rao; K R Reuhl; C M Witmer; R Snyder
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

7.  The benzene metabolite, hydroquinone and etoposide both induce endoreduplication in human lymphoblastoid TK6 cells.

Authors:  Zhiying Ji; Luoping Zhang; Weihong Guo; Cliona M McHale; Martyn T Smith
Journal:  Mutagenesis       Date:  2009-06-02       Impact factor: 3.000

8.  Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites.

Authors:  G Lévay; W J Bodell
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 9.  Deleterious effects of reactive metabolites.

Authors:  Sabry M Attia
Journal:  Oxid Med Cell Longev       Date:  2010 Jul-Aug       Impact factor: 6.543

10.  Formation and repair of tobacco carcinogen-derived bulky DNA adducts.

Authors:  Bo Hang
Journal:  J Nucleic Acids       Date:  2010-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.